| Line Item | 2022-07-31 | Y/Y |
|---|---|---|
| R&D Expense | $25.8M | -24.3% |
| SG&A Expense | $11.2M | -21.6% |
| Operating Income | -$37.0M | +23.5% |
| Interest Expense | $21K | +32.0% |
| Pre-tax Income | -$37.5M | +21.2% |
| Income Tax | -$3.3M | -38.2% |
| Net Income | -$34.2M | +24.3% |
| EPS (Basic) | -$0.87 | +36.5% |
| Line Item | 2022-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.3M | -73.2% |
| Current Assets | $15.2M | -69.0% |
| Total Assets | $21.9M | -61.1% |
| Current Liabilities | $6.6M | -16.7% |
| Long-term Debt | $937K | -24.1% |
| Total Liabilities | $15.8M | -13.4% |
| Stockholders' Equity | $6.1M | -83.9% |
| Line Item | 2022-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.1M | +23.1% |
| Capital Expenditures | $245K | -19.6% |
| Investing Cash Flow | -$245K | +69.4% |
| Financing Cash Flow | -$1.2M | -101.7% |
| Free Cash Flow | -$32.4M | +23.1% |